Search Results 951-960 of 15067 for transexamic

  1. Head and Neck Cancer Center - Specialty groups - Mayo Clinic

    Dr. Samir Patel collaborates with Mayo Clinic colleagues in Arizona. Mayo Clinic has one of the largest and most experienced practices in the United States, ...

  2. Ciprofloxacin (ophthalmic route) - Mayo Clinic

    Ciprofloxacin eye drops is also used to treat corneal ulcers of the eye. Ciprofloxacin belongs to a group of medicines called fluoroquinolone antibiotics. It ...

  3. Hyperoxaluria Center - Overview - Mayo Clinic

    This rare inherited kidney disease causes kidney stones. Symptoms most often occur during childhood or adolescence. Treatment may involve taking medications ...

  4. NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy - Mayo Clinic

    Neuropathy Symptom and Change Score (NSC); Physical component summary (PCS) score of 36-Item Short Form Survey (SF-36); Polyneuropathy disability (PND) score ...

  5. (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis - Mayo Clinic

    The purpose of this study to determine recommended dose (RD) of BLU-263 for patients with Indolent Systemic Mastocytosis. Participation eligibility. Participant ...

  6. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of depemokimab 200 mg subcutaneous (SC) given every 6 months versus placebo in participants with ...

  7. Clascoterone (topical application route) - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Cream. Back to top ...

  8. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    About this study. This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior ...

  9. A Phase Ib Study Of Cobimetinib Administered In Combination With Niraparib, With or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma - Mayo Clinic

    About this study. The primary purpose of this study is to determine if bortezomib, daratumumab, lenalidomide and dexamethasone (Btz-DRd) consolidation ...